|
|
|
|
| LEADER |
07049cam a2201093 i 4500 |
| 001 |
934742298 |
| 003 |
OCoLC |
| 005 |
20240223121953.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
160114s2016 nyua ob 001 0 eng d |
| 015 |
|
|
|a GBB952850
|2 bnb
|
| 016 |
7 |
|
|a 101680126
|2 DNLM
|
| 016 |
7 |
|
|a 019299083
|2 Uk
|
| 019 |
|
|
|a 932593456
|a 935249520
|a 981106100
|a 1005788774
|a 1011899695
|a 1048158048
|a 1066538544
|a 1110962343
|a 1112583134
|a 1113087768
|a 1113419901
|a 1117192715
|a 1122816413
|a 1127182498
|a 1136246470
|a 1155958390
|a 1159631092
|a 1160992606
|a 1204015379
|a 1228650757
|a 1237490828
|a 1244635311
|
| 020 |
|
|
|a 9781493929115
|q (electronic bk.)
|
| 020 |
|
|
|a 1493929119
|q (electronic bk.)
|
| 020 |
|
|
|z 9781493929108
|
| 020 |
|
|
|z 1493929100
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-2911-5
|2 doi
|
| 035 |
|
|
|a (OCoLC)934742298
|z (OCoLC)932593456
|z (OCoLC)935249520
|z (OCoLC)981106100
|z (OCoLC)1005788774
|z (OCoLC)1011899695
|z (OCoLC)1048158048
|z (OCoLC)1066538544
|z (OCoLC)1110962343
|z (OCoLC)1112583134
|z (OCoLC)1113087768
|z (OCoLC)1113419901
|z (OCoLC)1117192715
|z (OCoLC)1122816413
|z (OCoLC)1127182498
|z (OCoLC)1136246470
|z (OCoLC)1155958390
|z (OCoLC)1159631092
|z (OCoLC)1160992606
|z (OCoLC)1204015379
|z (OCoLC)1228650757
|z (OCoLC)1237490828
|z (OCoLC)1244635311
|
| 037 |
|
|
|a 879602
|b MIL
|
| 040 |
|
|
|a YDXCP
|b eng
|e rda
|e pn
|c YDXCP
|d OCLCO
|d OCLCF
|d OCLCQ
|d AZU
|d GW5XE
|d EBLCP
|d IDEBK
|d COO
|d KSU
|d UAB
|d JG0
|d OCLCQ
|d LVT
|d OCLCO
|d VT2
|d IAD
|d JBG
|d ICW
|d OCLCO
|d Z5A
|d ILO
|d ICN
|d OCLCQ
|d ESU
|d IOG
|d OCLCO
|d NJR
|d N$T
|d OCLCO
|d U3W
|d EZ9
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d UKMGB
|d OCLCO
|d UKAHL
|d OCLCQ
|d OCLCO
|d DCT
|d ERF
|d UKBTH
|d LEATE
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d LUU
|d OCLCQ
|d DKDLA
|d OCLCO
|d OCLCL
|
| 049 |
|
|
|a COM6
|
| 050 |
|
4 |
|a QR185.8.T24
|b T48 2016
|
| 060 |
|
4 |
|a QW 568
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 072 |
|
7 |
|a MMFP
|2 bicssc
|
| 082 |
0 |
4 |
|a 616.079
|2 23
|
| 245 |
0 |
4 |
|a The Th2 type immune response in health and disease :
|b from host defense and allergy to metabolic homeostasis and beyond /
|c William C. Gause, David Artis, Editors.
|
| 264 |
|
1 |
|a New York :
|b Springer,
|c [2016]
|
| 300 |
|
|
|a 1 online resource (xiv, 172 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 347 |
|
|
|a text file.
|
| 347 |
|
|
|b PDF.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Regulation and Function of Basophil, Eosinophil and Mast Cell Responses -- Innate lymphoid cells: An Emerging Population in type 2 Inflammation -- Dendritic Cells and Type 2 Inflammation -- Th2 Cell Responses in Immunity and Inflammation Following Helminth Infection -- Regulatory T Cell Control of Type 2 Inflammation -- Developments in the Design of Anti-Helminth Vaccines -- Tissue Remodeling and Repair During Type 2 Inflammation -- Immune Response to Helminth Infections and as Treatment for Autoimmune Disorders -- Type 2 Immunity and Metabolism.
|
| 520 |
|
|
|a The type 2 immune response that develops during infectious disease has undergone major paradigm shifts in the last several years as new cell types and pathways have been identified. It is now clear that the type 2 immune response, characterized by elevations in specific cytokines, including IL-4, IL-5 and IL-13, is associated with helminth infections in both humans and mice. This response is complex and includes effector functions that mediate resistance, contributing to expulsion, and in some cases destruction, of the parasite. But just as importantly, the type 2 immune response can also mediate tolerance mechanisms, which can mitigate tissue injury as these large multicellular parasites transit through vital organs. The tolerance mechanisms include both tissue repair and immune regulatory effects. These latter aspects of the helminth-induced type 2 immune response are increasingly recognized as a potential resource that can be mined for the development of novel immunotherapies that may enhance wound healing, control of autoimmune and inflammatory diseases and regulation of metabolic homeostasis. In this book, leading researchers in this exciting and dynamic field discuss the latest findings and emerging concepts, providing an intellectual framework that can be used as a basis for new discoveries and potentially new treatments for diseases associated with inflammation.
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Th2 cells.
|
| 650 |
|
0 |
|a Immune response
|x Regulation.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
2 |
|a Th2 Cells
|x immunology.
|
| 650 |
|
2 |
|a Microbiology.
|
| 650 |
|
6 |
|a Lymphocytes TH2.
|
| 650 |
|
6 |
|a Réaction immunitaire
|x Régulation.
|
| 650 |
|
6 |
|a Microbiologie.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh.
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh.
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh.
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh.
|
| 650 |
|
7 |
|a microbiology.
|2 aat.
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh.
|
| 650 |
|
7 |
|a Immune response
|x Regulation.
|2 fast.
|
| 650 |
|
7 |
|a Th2 cells.
|2 fast.
|
| 700 |
1 |
|
|a Gause, William C.,
|e editor.
|
| 700 |
1 |
|
|a Artis, David,
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks.
|
| 776 |
0 |
8 |
|i Print version:
|t Th2 type immune response in health and disease.
|d New York : Springer, [2016]
|z 9781493929108
|z 1493929100.
|
| 776 |
0 |
8 |
|i Print version:
|a Gause, William C.
|t Th2 Type Immune Response in Health and Disease.
|d Springer New York 2015
|z 1493929119
|w (OCoLC)932593456.
|
| 907 |
|
|
|a .b50717200
|b multi
|c -
|d 160510
|e 240320
|
| 998 |
|
|
|a (3)cue
|a cu
|b 240227
|c m
|d z
|e -
|f eng
|g nyu
|h 4
|i 2
|
| 948 |
|
|
|a MARCIVE Overnight, in 2024.03
|
| 936 |
|
|
|a BATCHLOAD
|
| 948 |
|
|
|a MARCIVE Comp, in 2023.01
|
| 948 |
|
|
|a MARCIVE Over, 07/2021
|
| 948 |
|
|
|a MARCIVE Comp, 2019.12
|
| 948 |
|
|
|a MARCIVE Comp, 2018.05
|
| 948 |
|
|
|a MARCIVE August, 2017
|
| 948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
| 994 |
|
|
|a 92
|b COM
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2024.03
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2024.02
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2023.01
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2021.07
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2021.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2019.12
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2018.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2017.09
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2016
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2016
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2016
|
| 995 |
|
|
|a OCLC offline update by CMU
|
| 999 |
|
|
|e z
|
| 999 |
|
|
|a cue
|
| 989 |
|
|
|d cueme
|e - -
|f - -
|g -
|h 0
|i 0
|j 200
|k 240227
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w SpringerLink
|1 .i150448235
|u http://ezproxy.coloradomesa.edu/login?url=https://link.springer.com/10.1007/978-1-4939-2911-5
|3 SpringerLink
|z Click here for access
|